Infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: "In the study group, blood samples (16 to 20 milliliters) will be taken from patients on day 1, and PBMCs will be isolated using centrifugation. After centrifugatio
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: All patients have had three or more repeated implantation failures in IVF-ET treatment Age < 40
Exclusion criteria
Exclusion criteria: Patient's immune deficiency Unwillingness to cooperate and participate in the study Patients suffering from disorders such as: hydrosalpinx, Asherman syndrome, organic endometrial disease, chromosomal abnormalities and severe endometriosis, chromosomal abnormalities, presence of antiphospholipid antibodies, mutations related to coagulation system parts, such as deficiency of factor XII, protein C, and protein S Patients with thin endometrium (endometrium less than 7 mm on the day of ET)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performing pregnancy tests and follow-up ultrasound for pregnancy diagnosis. Timepoint: Pregnancy test 12 days after ET and 30 days after a positive pregnancy test. Method of measurement: Blood test.;Observing the number and location of gestational sacs. Timepoint: 30 days after a positive pregnancy test. Method of measurement: TVS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Live birth. Timepoint: After delivery. Method of measurement: Clinical. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRaha Karami
Shiraz University of Medical Sciences
Outcome results
None listed